Fachliteratur Gastroenterologie: Neoplasien Pankreas

Fr | De

Feedback | Impressum | Sitemap

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Fachliteratursuche » Pankreas » Neoplasie

23. August 2026

Abklärungen / Diagnostik

Therapien

Guidelines

Fortbildung

News / Journalscreening

Schrift:

Seite 1 von 3063


	Artikel 1 - 20 / 61250

	Exploration of the mechanism of gut microbiota-mediated immune modulation in the pathogenesis of pancreatic cancer: A Mendelian randomization study. Medicine (Baltimore) Cai M, Cheng H, Jia Y, Qiu T, Liu Z, Xu J, Li H, Zhang Z, Wang J. PMID: 42629734 [PubMed - indexed for MEDLINE]
	A retrospective comparative study of CT and MRI findings of different types of pancreatic serous cystic neoplasms: Correlation with histopathology. Medicine (Baltimore) Li G, Lei A, Zhao J, Wang P, Ji G, Han X, Li P, Li B. PMID: 42629710 [PubMed - indexed for MEDLINE]
	Development and preliminary evaluation of a Neuman Systems Model-based protocol for postoperative delirium prevention in patients undergoing pancreatic cancer surgery. Medicine (Baltimore) Wang S, Yu L, Xu W. PMID: 42629707 [PubMed - indexed for MEDLINE]
	Clinical Translation of Patient-Derived Organoids: Perspectives for Personalized Therapy in Cancer. Int J Cancer Yue H, Carchidi D, Schmucker P, Seiler R, Kiss B, Macedo-Silva C, Kruithof-de Julio M. PMID: 42629644 [PubMed - as supplied by publisher]
	Seamless Phase I-II Cancer Clinical Trials Using Kernel-Based Covariate Similarity. Pharm Stat Makino K, Makigusa N, Kojima M. PMID: 42629327 [PubMed - indexed for MEDLINE]
	Emerging Issue - Fatty Pancreas in Pancreatic Cystic Neoplasms: Results of a Matched Case-Control Study. Dig Dis Sci Vl, Bilous D, Sandru V, Buz, Prodan R, Bugeac C, Chiriac O, Tianu E, Ciocîrlan M. PMID: 42627603 [PubMed - as supplied by publisher]
	Exploring facilitators and barriers to the implementation of prehabilitation for individuals with pancreatic cancer: a survey of healthcare professionals. Support Care Cancer Wrench E, McGladrigan E, Lauder RM, Dunne D, Shelton C, Lambert J, Machin LL, Subar DA, Bampouras TM, Gaffney CJ. PMID: 42627527 [PubMed - indexed for MEDLINE]
	Solid Pseudopapillary Neoplasm of the Pancreas: Diagnostic Concordance and Clinicopathologic Correlation of Fine-Needle Aspiration and Long-Term Outcomes. Cureus Dejban P, Wang EZ, Ahsan BU, Yuan L. PMID: 42626592 [PubMed]
	Risk prediction models for malnutrition in patients with cancer: a systematic review. Front Nutr Jiang K, Pan J, Zhang Y. PMID: 42626291 [PubMed]
	Distinct prognostic impact of diabetes subtypes, metformin use, and glycemic control in pancreatic cancer: a systematic review and meta-analysis of cohort studies. Front Oncol Li G, Peng Z, Wang Y, Zhu Z, Huang S, Yu J, Huang H. PMID: 42625611 [PubMed]
	Prognostic utility of the Charlson comorbidity index in pancreatic cancer: a systematic review and metaâ€‘analysis. World J Surg Oncol Yang J, Wang S, Bai X, Song H. PMID: 42625189 [PubMed - indexed for MEDLINE]
	Human endogenous retroviruses as immune-related prognostic biomarkers in pancreatic cancer. BMC Cancer Toma PI, Gales LN, Ghiringhelli F, Trandafir A, Budea RI, Ilie SM. PMID: 42625160 [PubMed - indexed for MEDLINE]
	Pan-cancer profiles of mesothelin (MSLN) unveil diagnostic potential and therapeutic targetability of pancreatic adenocarcinoma. PLoS One Sheikh MR, Mistry B, Shafin RH, Apu A, Sara TH, Tasnim J, Dutta D, Nandy A, Rahman A. PMID: 42623414 [PubMed - indexed for MEDLINE]
	Incidental cystic pancreatic neuroendocrine neoplasm and differential diagnosis. Radiol Case Rep Martin D, Taylor ER, Abdallah E, Haider M, Ferguson K, Jeong D, Feuerlein S, Costello JR. PMID: 42621430 [PubMed]
	Meta-analysis of the relationship between preoperative systemic immune inflammation index and prognosis of patients with biliary tract cancer. Biomark Med Liang J, Wang Z, Lv D, Tuo H. PMID: 42619611 [PubMed - as supplied by publisher]
	Zinc-based nanoplatforms for cancer immunotherapy achieved through the cyclic GMP-AMP synthase-stimulator of interferon genes pathway: Bridging tumor metabolism and immune activation. Acta Biomater Wang Y, Wang Y, Zhang C, Li D, Fu X, Wang T, Zhang L, Wang Y. PMID: 42617782 [PubMed - as supplied by publisher]
	ESMO Clinical Practice Guideline Express Update on daraxonrasib in the treatment of metastatic pancreatic cancer. Ann Oncol Conroy T, Ducreux M, ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. PMID: 42617733 [PubMed - as supplied by publisher]
	What matters most early in the cancer trajectory: patient concerns and priorities in pancreatic and lung cancer (BetterEveryDay trial). Eur J Oncol Nurs Mikkelsen MK, Rolin L, Theile S, Markman MJN, Hald C, Chen IM. PMID: 42617508 [PubMed - as supplied by publisher]
	Biofabrication and artificial intelligence strategies for investigating solid- and fluid-pressure mechanobiology in pancreatic ductal adenocarcinoma. Cancer Metastasis Rev Ding Y, Zhao P, Jin Y, Li Y, Wang Z, Lu Y, Zhang Y, Chen H, Zhang W, Luan X, Tang M. PMID: 42616191 [PubMed - indexed for MEDLINE]
	Chemotherapy for Unresectable Pancreatic Cancer Complicated by Disseminated Intravascular Coagulation: A Retrospective Cohort Study. Pancreas Nagata K, Ando T, Kawanaka H, Sakamoto J, Ogino B, Entani T, Motoo I, Ueda Y, Hayashi N, Kajiura S, Tajiri K, Yasuda I. PMID: 42616029 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 61250

Seite 1 von 3063



		Zeitfenster

Ironmedline

Das Fachportal für Eisenmangel >>

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung